4.6 Article

Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan

Related references

Note: Only part of the references are listed.
Article

Insights on carbapenem-resistant Acinetobacter baumannii

Matthew Gavino Donadu et al.

Acta Biologica Szegediensis (2021)

Article Microbiology

Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model

Maya Beganovic et al.

Summary: Triple therapy with high-dose minocycline, continuous-infusion sulbactam, and polymyxin B demonstrated the most significant kill against carbapenem-resistant Acinetobacter baumannii, with no regrowth and minimal resistance development in an in vitro pharmacodynamic model.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Immunology

Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms

Xiufeng Zhang et al.

Summary: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a significant concern in hospitals worldwide. A study in a Chinese hospital ICU over six years found that all 105 CRAB isolates belonged to a global clone CC2, with some popular clones and significant differences in community structure over time. The findings suggest a potential clone outbreak in the hospital ICU, highlighting the substantial burden of multidrug-resistant CRAB in this environment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Infectious Diseases

In Vitro Activity of Minocycline Against Multidrug-Resistant Acinetobacter baumannii Isolates-Evaluation of Clinical Breakpoints and Review of Literature

Carlos Hernan Rodriguez et al.

Summary: Minocycline has excellent activity against multidrug-resistant Acinetobacter baumannii, but there is no unified criteria for its breakpoints. Tetracycline susceptibility can be used as a screening to differentiate populations with and without acquired resistance mechanisms to MIN.

MICROBIAL DRUG RESISTANCE (2021)

Review Infectious Diseases

Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future

Arezoo Asadi et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)

Article Immunology

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

Yohei Doi

CLINICAL INFECTIOUS DISEASES (2019)

Article Infectious Diseases

Minocycline susceptibility breakpoints for Acinetobacter baumannii: do we need to re-eval uat them?

Athanasios Tsakris et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Infectious Diseases

Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016)

Tanya Strateva et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)

Article Infectious Diseases

Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii

Olga Lomovskaya et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)

Review Microbiology

Mobile Genetic Elements Associated with Antimicrobial Resistance

Sally R. Partridge et al.

CLINICAL MICROBIOLOGY REVIEWS (2018)

Review Microbiology

Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges

Darren Wong et al.

CLINICAL MICROBIOLOGY REVIEWS (2017)

Article Infectious Diseases

Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection

Wadha A. Alfouzan et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)

Article Microbiology

In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii

David M. Livermore et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Article Immunology

A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Acinetobacter Infections

David J. Ritchie et al.

CLINICAL INFECTIOUS DISEASES (2014)

Article Microbiology

Emergence and Spread of Plasmid-Borne tet(B)::ISCR2 in Minocycline-Resistant Acinetobacter baumannii Isolates

Elisabet Vilacoba et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Infectious Diseases

Antibiotic resistance islands in A320 (RUH134), the reference strain for Acinetobacter baumannii global clone 2

Steven J. Nigro et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Infectious Diseases

Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate

Steven J. Nigro et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Review Microbiology

Efflux-Mediated Antibiotic Resistance in Acinetobacter spp.

Sebastien Coyne et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)